scientific advisory board
carol a. barnes, ph.d.
One of the worlds leading neuroscientists and an expert in memory biology and aging with over 30 years experience in the field. Director of the Evelyn F. McKnight Institute and a regents' professor in the Departments of Psychology and Neurology at the University of Arizona.
Roberta diaz Brinton, ph.d.
Roberta Diaz Brinton, PhD, is the director of the UA Center for Innovation in Brain Science at the University of Arizona Health Sciences. Dr. Brinton is a leading neuroscientist in the field of Alzheimer’s, the aging female brain and regenerative therapeutics.
Costantino Iadecola, M.D.
A world leader in vascular dementia with nearly 30 years experience in neurology and neuroscience. Dr. Iadecola is the Director of the Brain and Mind Research Institute Weill Cornell Medical College and Professor of Neurology and Neuroscience Weill Cornell Medical College.
Eric Reiman, M.D.
International leader in the area of developing new therapies to prevent and treat Alzheimer’s disease. CEO of Banner Research and Executive Director of the Banner Alzheimer’s institute in Phoenix, AZ International renowned clinical Has over 25 years experience in dementia and Alzheimer’s disease.
todd vanderah, ph.d.
Dr. Vanderah is Head and Professor of Pharmacology, and is a Professor in the Departments of Neurology and Anesthesiology. With over 25 years experience, he is an international leader mechanisms of pain, neuronal integration in pain pathways and novel targets for drug discovery.
Raymond Woosley, M.D., Ph.D.
Dr. Woosely has over 30 years experience in clinical research, developing new therapeutics, and working with the FDA. The founding President and Chairman of the Board for AZCERT and founder and past President of Critical Path Institute (C-Path).